Original article
Genital chlamydia infections in sexually active female adolescents: Do we really need to screen everyone?

https://doi.org/10.1016/S1054-139X(96)00157-7Get rights and content

Purpose:

To evaluate current Chlamydia trachomatis screening guidelines, which recommend that all sexually active female adolescents undergoing a pelvic examination be tested for chlamydial infection, and determine if instead providers should target particular subpopulations of these adolescents.

Methods:

Data were collected from 148,650 sexually active females, ages 15–19 years, tested by direct immunofluorescent antibody in 160 family planning clinics from 1988–92. Trends in chlamydia prevalence by demographic, behavioral, and clinical risk factors were analyzed. Logistic regression modeling was used to identify selective screening criteria. Predictive models were developed for all years combined, as well as for the years when prevalence was highest and lowest.

Results:

The prevalence of C. trachomatis in this population was 10%, with a 42% decrease (13.2–7.6%) over the 5-year period. Logistic regression identified nine demographic, behavioral, and clinical predictors (p < 0.0001) associated with chlamydial infections. Predictor models from the highest and lowest prevalence years varied little from the combined model. Individual year predictor models showed poor sensitivity and were similar for these 2 years. The screening criteria could not identify a group of adolescents with a prevalence less than 6%.

Conclusions:

Several individual risk factors were strongly associated with C. trachomatis, but no single risk factor or combination of risk factors used for selective screening could identify more than 42% of infections in our population. These findings support earlier national recommendations and the need for universal screening of sexually active female adolescents.

References (29)

  • MacaulayME et al.

    A prospective study of genital infections in a family-planning clinic. 2. chlamydia infection—the identification of a high-risk group

    Epidemiol Infect

    (1990)
  • HandsfieldHH et al.

    Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics

    JAMA

    (1986)
  • MalotteCK et al.

    Screening for chlamydial cervicitis in a sexually active university population

    Am J Public Health

    (1990)
  • WeinstockHS et al.

    Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations?

    Am J Epidemiol

    (1992)

    • Cited by (74)

    • Chlamydia Prevalence and Correlates Among Female Adolescents in Hungary

      2007, Journal of Adolescent Health

    • Contraception in French teenage girls in 2007

      2007, Gynecologie Obstetrique et Fertilite

    • Urinary Symptoms in Adolescent Females: STI or UTI?

      2007, Journal of Adolescent Health
      Citation Excerpt :

      The guidelines for vaginitis [13] recommend STI testing for those “at risk.” The literature contains many reports that link patient history variables to STI risk; however, our findings confirm those of others [14–16] who have shown that risk factors alone are inadequate at delineating a sample that requires STI screening. In addition, we demonstrated that there is a large overlap in self-reported vaginal and urinary symptoms in adolescent women.

    • Chlamydia trachomatis: Common misperceptions and misunderstandings

      2005, Journal of Pediatric and Adolescent Gynecology
      Citation Excerpt :

      To reduce the prevalence of CT and its costly sequelae at the population level, individuals with positive test results and their partners must be treated. Projections about the costs and benefits of clinic-based CT-screening programs take into account the fact that many patients who test positive for this infection are never notified of their test results or treated, and even fewer notify their sexual partners.17,29,32,64,109–122 However, absent information about the follow-up of asymptomatic patients who test positive for CT on specimens they collect at home or they or their care providers collect in other non-clinic settings, findings about the efficacy of screening clinic populations cannot be extrapolated to non-clinic populations.17

    • The epidemiology of sexually transmitted infections in adolescents

      2005, Seminars in Pediatric Infectious Diseases

    • Diagnostic tests for chlamydial and gonorrheal infections

      2005, Seminars in Pediatric Infectious Diseases
    View all citing articles on Scopus

    This paper is based on dissertation research by Dr. Debra J. Mosure in partial fulfillment of the requirements for the Ph.D. degree at Emory University.

    View full text
    Copyright © 1997 Published by Elsevier Inc.